ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 163 filers reported holding ZAI LAB LTD in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,271 | +10.5% | 34,357 | -8.3% | 0.06% | +23.4% |
Q4 2022 | $1,150 | -99.9% | 37,447 | -8.4% | 0.05% | -34.7% |
Q3 2022 | $1,398,000 | +0.3% | 40,885 | +1.7% | 0.07% | +44.0% |
Q2 2022 | $1,394,000 | -15.4% | 40,191 | +7.3% | 0.05% | -26.5% |
Q1 2022 | $1,647,000 | -23.2% | 37,449 | +9.7% | 0.07% | +25.9% |
Q4 2021 | $2,145,000 | -53.8% | 34,134 | -22.5% | 0.05% | -43.8% |
Q3 2021 | $4,639,000 | -43.1% | 44,022 | -4.5% | 0.10% | -60.7% |
Q2 2021 | $8,156,000 | +37.8% | 46,082 | +3.9% | 0.24% | +9.4% |
Q1 2021 | $5,918,000 | +39.4% | 44,350 | +41.4% | 0.22% | +33.5% |
Q4 2020 | $4,246,000 | +120.7% | 31,374 | +35.6% | 0.17% | +87.6% |
Q3 2020 | $1,924,000 | +53.6% | 23,136 | +51.7% | 0.09% | +18.7% |
Q2 2020 | $1,253,000 | +253.0% | 15,256 | +121.4% | 0.08% | +294.7% |
Q1 2020 | $355,000 | +8775.0% | 6,890 | +6790.0% | 0.02% | – |
Q4 2019 | $4,000 | -20.0% | 100 | -35.5% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 155 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | – | 155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |